Research News
OCRF Talk with Lin Zhang, M.D.
In an interview, 3-time grantee Dr. Zhang discusses his research and what it means to receive an award from OCRF…
Report from ASCO 2013–What's New in Ovarian Cancer Research
We recently returned from the annual meeting of the American Society of Clinical Oncology (ASCO), an annual event that gathers thousands of cancer researchers from around the world…
Supreme Court Strikes Down BRCA Gene Patents
In a unanimous ruling issued June 13, 2013, the US Supreme Court ruled that private companies do not have the right to patent human genes. In Association for Molecular Pathology et al. v…
June 2013 SNMMI Meeting
Society for Nuclear Medicine and Molecular Imaging (SNMMI) Advocate Report from Laurel Pracht As a member of the SNMMI Advocate Advisory Board, formed in 2010 to better bridge the gap between the patient and nuclear medicine communities, I represent…
Press Release: Ovarian Cancer Advocates Praise Supreme Court Decision on Gene Patents
Ruling Will Give Women More Options to Learn About Genetic Risk Washington, DC—The Supreme Court ruled today that a company cannot patent naturally occurring genes, including isolated gene segments, overturning a decision made by the United States…
New Meta-Analysis of Oral Contraception and Risk of Ovarian Cancer
A new meta-analysis of more than 6000 studies shows that oral contraceptives significantly reduce the risk of ovarian cancer. The risk reduction increases proportionally with duration of use…
ASCO News: Weekly Chemo Improves Quality of Life
In research presented at the American Society of Clinical Oncology meeting this week, researchers found that shortening the break between chemotherapy sessions improved quality of life for patients, without negatively impacting efficacy…
ASCO News: Kidney Cancer Drug Delays Ovarian Cancer Relapse
Research presented at the American Society of Clinical Oncology annual meeting this week suggests that adding the drug pazopanib (trade name Votrient) to standard treatment extends progression-free survival in ovarian cancer patients by 5.6 months…
Ovarian Cancer Incidence Fell Along with Hormone Therapy Use
In a study published online in the Journal of Clinical Oncology on May 6, 2013, researchers reported results of a study investigating menopausal hormonal therapy (MHT) use and the incidence of ovarian cancer…
NCCN Releases Updated Guidelines for Ovarian Cancer Patients
The National Comprehensive Care Network has released updated guidelines for patients with ovarian cancer…
Decreases in Ovarian Cancer Correlate to Decrease in Use of Hormone Replacement Therapy
A new study shows that rates of ovarian cancer decreased around the same time that the use of hormone replacement therapy dropped off…
Update on Treatment for Recurrent Ovarian Cancer
A new article summarizes treatment options for women with recurrent ovarian cancer. The article includes information about when to treat a recurrence, what agents are available and the goals of therapy…